Can carpal tunnel surgery restore more than hand function?

NCT ID NCT07806071

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 08, 2026 · Last updated Sep 09, 2026 · Updated 1 time

Summary

This study follows adults with carpal tunnel syndrome who are scheduled for carpal tunnel release surgery. Researchers will measure sleep quality, fatigue, fear of movement, pain, and hand function before surgery and again at 4 and 8 weeks after. The goal is to see how these factors change after surgery and whether better sleep and less fatigue are linked to reduced pain and improved hand use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Carpal tunnel release surgery (standard procedure, not modified by the study)
What this could lead to
If improvements in sleep and fatigue after surgery are linked to better pain and hand function, it could point to recovery strategies that address sleep and fear of movement.
What could go wrong
This is an observational study, so it cannot prove cause and effect. Results may not apply to everyone, and surgery carries usual risks like infection or nerve damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will consist of adults with clinically and electrophysiologically confirmed carpal tunnel syndrome who are scheduled to undergo unilateral primary carpal tunnel release surgery as part of routine clinical care at Medipol Hospitals in Istanbul, Türkiye. Eligible patients will be invited to participate before surgery and will be followed prospectively at postoperative Weeks 4 and 8. The decision to perform surgery and the choice of surgical technique will be made by the treating physician independently of study participation.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 to 70 years. * Clinical and electrophysiological diagnosis of carpal tunnel syndrome. * Scheduled to undergo unilateral primary carpal tunnel release surgery as part of routine clinical care. * Ability to read and understand Turkish. * Sufficient cognitive ability to understand and complete the study questionnaires. * Willingness to participate and provision of written informed consent. * Ability and willingness to complete the preoperative and postoperative follow-up assessments. For participants with bilateral carpal tunnel syndrome, only the surgically treated hand will be designated as the index hand and included in the study assessments. Exclusion Criteria: * Previous carpal tunnel release surgery on the index hand. * Scheduled revision carpal tunnel surgery. * Simultaneous bilateral carpal tunnel release surgery. * Concomitant severe cervical radiculopathy, brachial plexus lesion, ulnar neuropathy, radial neuropathy, or another neurological or orthopedic condition that substantially affects upper extremity function. * Severe rheumatologic or neurodegenerative disease affecting upper extremity function. * Cognitive impairment or severe psychiatric illness that prevents understanding or completion of the study assessments. * Uncontrolled systemic disease that may interfere with participation or follow-up. * New trauma or additional surgery affecting the same upper extremity during the follow-up period. * Inability to complete the planned follow-up assessments. * Refusal or withdrawal of informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Carpal tunnel syndrome (CTS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.